NEW YORK, NY – August 24, 2022 – The Lupus Research Alliance (LRA) today announced its Global Team Science Award (GTSA) has been granted to three international research teams from 14 institutions across four continents comprised of leading experts spanning in immunology, rheumatology, neurosciences, biomedical engineering, genomics and genetics, and public health. With $3 million […] READ MORE
NUEVA YORK, NY. 10 de agosto de 2022. Lupus Research Alliance (LRA) se complace en anunciar el nombramiento de Albert Roy como presidente y director ejecutivo a partir del 6 de septiembre de 2022. El Sr. Roy actualmente se desempeña como director ejecutivo de Lupus Therapeutics, la filial que se encarga de los ensayos clínicos […] READ MORE
NEW YORK, NY. August 10, 2022 – The Lupus Research Alliance (LRA) is pleased to announce the appointment of Albert Roy to President and Chief Executive Officer effective September 6, 2022. Mr. Roy currently serves as Executive Director of Lupus Therapeutics, the clinical trial affiliate of the Lupus Research Alliance. He will succeed Kenneth M. […] READ MORE
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food and Drug Administration (FDA) has approved belimumab (Benlysta®) as the first-ever treatment specifically indicated for children aged 5 to 17 with lupus nephritis. Belimumab is already approved by the FDA to treat lupus nephritis in adults […] READ MORE
July 25, 2022 During a time when health and wellness are top of mind, many are looking for creative ways to boost their own well-being — and at the same time seeking opportunities to do something truly meaningful for others. Whether you or someone you care about is living with lupus or not, you can […] READ MORE
June 23, 2022 The Lupus Research Alliance (LRA) is pleased to award its 2022 Lupus Insight Prize (LIP) to Akiko Iwasaki, PhD, for her discovery of the link between endogenous retroviruses and systemic lupus erythematosus (SLE). The award was presented to Dr. Iwasaki at the 22nd Annual Meeting of the Federation of Clinical Immunology Societies […] READ MORE
NEW YORK, NY, June 9, 2022. The Lupus Research Alliance (LRA), the world’s leading private funder of lupus research, today announced inaugural recipients of Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research. The Diversity in Lupus Research Award funding mechanisms aim to address underrepresentation of minorities in the scientific research profession. Lupus […] READ MORE
The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive results from a Phase 2 trial of the investigational agent deucravacitinib as a possible treatment for systemic lupus erythematosus (SLE). Data showed that a significantly higher percentage of patients treated with the study drug met the […] READ MORE
May 14, 2022 EAST RUTHERFORD, NEW JERSEY. May 14, 2022. The Lupus Research Alliance (LRA) brought together thousands of people to MetLife Stadium for the 2022 New Jersey Walk with Us to Cure Lupus to raise lupus awareness. The MetLife walk marked the 20th anniversary of the LRA’s national Walk Program. As Honorary Chair of […] READ MORE
SUMMIT, N.J., May 2, 2022 /PRNewswire/ — Kicking off Lupus Awareness Month, former Super Bowl Champion and Mad Dog Sports radio personality Willie Colon hosted today the 8th Annual Willie Colon Golf Outing crafted by Tito’s Handmade Vodka for the Lupus Research Alliance (LRA). Mr. Colon is an active member of the Lupus Research Alliance Board […] READ MORE
NEW YORK, NY. January 27 — The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) announced two major initiatives improving representation of minorities in clinical trials and the scientific research profession: Project CHANGE by LT and the Diversity in Lupus Research Program. The LRA has been addressing these disparities for many years and now proudly launches this […] READ MORE
NEW YORK, NY, December 14, 2021. The Lupus Research Alliance proudly announced today recipients from the U.S. and around the world of the 2021 Lupus Innovation Award which will fund wide ranging areas of research from probing the development and progression of lupus to pointing to potential personalized therapies. The Lupus Innovation Award provides support […] READ MORE
